Group One Trading
ELDN icon

Group One Trading’s Eledon Pharmaceuticals ELDN Stock Holding History

Group One Trading’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$333K Buy
108,100
+75,600
+233% +$178K ﹤0.01% 3713
2025
Q4 		$49.1K Buy
+32,500
New +$77.3K ﹤0.01% 5618
2025
Q1 		– Sell
-900
Closed -$3.71K – 7788
2024
Q4 		$3.71K Buy
+900
New +$3.55K ﹤0.01% 6540
2023
Q2 		– Sell
-1,200
Closed -$2.83K – 7781
2023
Q1 		$2.83K Buy
+1,200
New +$3.21K ﹤0.01% 6513

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Group One Trading's ELDN Position: Q1 2026 in Review

Group One Trading opened a new position in Eledon Pharmaceuticals (ELDN) in Q1 2026: 29,874 shares worth $92K. The stake represents ﹤0.01% of the portfolio and ranks #4811 among its holdings. This is a return to the name: Group One Trading previously reported a position in ELDN as recently as Q3 2025.

Group One Trading first reported a position in ELDN in Q1 2023 and has held it in 10 quarters since. 121 funds tracked by Wall St. Rank hold ELDN as of Q1 2026.

  • Group One Trading held 29,874 shares of Eledon Pharmaceuticals worth $92K as of Q1 2026.
  • Eledon Pharmaceuticals was a new Group One Trading position in Q1 2026.
  • Eledon Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4811 holding.
  • Group One Trading first reported a position in Eledon Pharmaceuticals in Q1 2023 and has held it in 10 quarters since.
  • 121 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.